The role of tumor-associated endothelial cells in malignant progression and immune evasion of liver cancer
- 12 June 2025
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 161, 115013
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82373894)
- Natural Science Foundation of Shaanxi Province (2025JC-YBMS-183)
This publication has 87 references indexed in Scilit:
- Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and ThrombosisCancer Medicine, 2024
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- The role of PLVAP in endothelial cellsCell and tissue research, 2023
- A Review on Nano-Based Drug Delivery System for Cancer ChemoimmunotherapyNano-Micro Letters, 2020
- Tumor angiogenesis: causes, consequences, challenges and opportunitiesCellular and Molecular Life Sciences, 2019
- Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancerCancer, 2011
- Chemokines and cancerInternational Journal of Cancer, 2006
- Plasmalemmal vesicle‐associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor‐A (VEGF)The Journal of Pathology, 2005
- Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinomaMolecular Carcinogenesis, 1997
- Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypesBioEssays, 1994